#USA #New York #Class Action #Pomerantz #GPGI

Investor Alert: Class Action Lawsuit Filed Against GPGI, Inc.

Pomerantz LLP, a notable firm specializing in securities class action lawsuits, has issued a notification to investors regarding significant legal developments concerning GPGI, Inc. This alert is particularly relevant for those who have experienced financial losses related to their investments in GPGI (listed on NYSE under the symbol GPGI). The firm encourages affected investors to get in touch if they wish to be involved in the ongoing class action lawsuit.

Background of the Case

The class action lawsuit centers around allegations of securities fraud and other illegal activities related to GPGI's business practices. If you are a shareholder who acquired GPGI securities during the class period, it is essential to contact Danielle Peyton at Pomerantz by email at [email protected] or reach out by phone at 646-581-9980. For toll-free inquiries, you can use 888.4-POMLAW and request extension 7980. To ensure effective communication, it is advised to include your mailing address, phone number, and the number of shares you purchased when reaching out.

Key Deadlines

Investors have until September 14, 2026, to file a motion to be appointed as Lead Plaintiff in this lawsuit. This is a crucial step as the appointed Lead Plaintiff will represent the interests of all investors in the class.

In addition, interested parties can access a copy of the class action complaint via the Pomerantz Law Firm's official website at www.pomerantzlaw.com.

Financial Recap of GPGI

GPGI recently announced its financial results for the fourth quarter and the entire fiscal year of 2025. For 4Q25, the company reported net sales of $520.8 million, reflecting a 6.1% increase from the previous year. The total sales for FY25 reached $1.5687 billion, up 5% year-over-year. However, notable declines included a 5.4% drop in Pro Forma Adjusted EBITDA for 4Q25, resulting in $136.1 million. Furthermore, the EBITDA margins saw a considerable compression of 318 basis points, signaling potential financial turmoil.

Following the earnings announcement on March 12, 2026, GPGI's stock fell $3.23 per share, amounting to a 16.36% drop by the close of trading the next day, settling at $16.51 per share.

Moreover, GPGI's 1Q26 financial results released on May 7, 2026, painted a troubling picture for the company. The reported Pro Forma Adjusted Net Sales decreased to $290.8 million, a decline of 5.2% year-over-year. Additionally, Pro Forma Adjusted EBITDA experienced a steep reduction to $38 million, which translates to a 40.2% year-over-year drop.

GPGI has also revised its guidance for 2026, dramatically lowering expected revenues from an initial forecast of $2.183 billion to $2.228 billion down to a new range of $1.95 billion to $2.10 billion. Similarly, the EBITDA estimates were adjusted downwards, estimating between $550 million and $610 million, down from a previous range of $620 million to $650 million.

As a direct consequence of this sobering financial news, GPGI's stock price took another hit, closing at $12.94 per share, reflecting a 25.89% plunge following the report.

Pomerantz Law Firm's Legacy

Founded by Abraham L. Pomerantz, who is often referred to as the dean of the class action bar, Pomerantz LLP has a long-standing reputation as one of the leading firms in corporate, securities, and antitrust class litigation. The firm has successfully recovered significant damages for victims of corporate misconduct and securities fraud for over 85 years. Today, it continues this tradition with vigor, advocating for investors and shareholders alike.

As this situation evolves, investors impacted by GPGI's recent announcements are advised to stay updated on the class action lawsuit developments and to consult with Pomerantz LLP to understand their rights and options moving forward.